| Cover | Oct. 22, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Oct. 22, 2024 |
| Entity File Number | 001-41964 |
| Entity Registrant Name | Chromocell Therapeutics Corporation |
| Entity Central Index Key | 0001919246 |
| Entity Tax Identification Number | 86-3335449 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 4400 Route 9 South |
| Entity Address, Address Line Two | Suite 1000 |
| Entity Address, City or Town | Freehold |
| Entity Address, State or Province | NJ |
| Entity Address, Postal Zip Code | 07728 |
| City Area Code | (877) |
| Local Phone Number | 265-8266 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.0001 per share |
| Trading Symbol | CHRO |
| Security Exchange Name | NYSEAMER |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
